NM_058216.3:c.1127_1129delTAT
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PM4_Supporting
The NM_058216.3(RAD51C):c.1127_1129delTAT(p.Leu376del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,459,096 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_058216.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000405 AC: 1AN: 246642Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 133158
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1459096Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 725578
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
The c.1127_1129delTAT variant (also known as p.L376*) is located in coding exon 9 of the RAD51C gene. This variant results from an in-frame TAT deletion at nucleotide positions 1127 to 1129. This changes the amino acid from a leucine to a stop codon within coding exon 9. This alteration occurs at the 3' terminus of theRAD51C gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last amino acid of the protein. The exact functional effect of this alteration is unknown. Based on the available evidence, the clinical significance of this variant remains unclear. -
- -
not provided Uncertain:1
Not observed at a significant frequency in large population cohorts (Lek 2016); Nonsense variant predicted to result in protein truncation with a loss of the last amino acid in the protein; Has not been previously published as pathogenic or benign to our knowledge -
Fanconi anemia complementation group O Uncertain:1
This sequence change creates a premature translational stop signal (p.Leu376*) in the RAD51C gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1 amino acid(s) of the RAD51C protein. This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with RAD51C-related conditions. ClinVar contains an entry for this variant (Variation ID: 490119). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at